{"id":"https://openalex.org/W7225264755","doi":"https://doi.org/10.1136/jitc-2026-016430","title":"Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy","display_name":"Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225264755","doi":"https://doi.org/10.1136/jitc-2026-016430","pmid":"https://pubmed.ncbi.nlm.nih.gov/42982510","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13735263"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-016430","doi":"https://doi.org/10.1136/jitc-2026-016430","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-016430","pdf_url":"https://jitc.bmj.com/content/14/11/e016430.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/11/e016430.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033235594","display_name":"Victor Arias","orcid":"https://orcid.org/0000-0002-3631-2896","observed_orcids":["https://orcid.org/0000-0002-3631-2896"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Victor Arias","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0000-0002-3631-2896","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036205283","display_name":"James H.A. Clubb","orcid":"https://orcid.org/0000-0002-9146-4817","observed_orcids":["https://orcid.org/0000-0002-9146-4817"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"James H Clubb","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027603010","display_name":"Tatiana Viktorovna Kudling","orcid":"https://orcid.org/0000-0003-4481-1617","observed_orcids":["https://orcid.org/0000-0003-4481-1617"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tatiana V Kudling","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022473081","display_name":"Elise Jirovec","orcid":"https://orcid.org/0009-0004-0606-6577","observed_orcids":["https://orcid.org/0009-0004-0606-6577"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Elise Jirovec","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0009-0004-0606-6577","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009672863","display_name":"Santeri Artturi Pakola","orcid":"https://orcid.org/0000-0001-6235-8612","observed_orcids":["https://orcid.org/0000-0001-6235-8612"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Santeri Artturi Pakola","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0000-0001-6235-8612","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052034162","display_name":"Lyna Haybout","orcid":"https://orcid.org/0009-0005-5170-5611","observed_orcids":["https://orcid.org/0009-0005-5170-5611"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Lyna Haybout","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0009-0005-5170-5611","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054296634","display_name":"Dafne C.A. Quixabeira","orcid":"https://orcid.org/0000-0003-2614-3942","observed_orcids":["https://orcid.org/0000-0003-2614-3942"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Dafne C A Quixabeira","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102737024","display_name":"Mirte van der Heijden","orcid":"https://orcid.org/0009-0000-4123-6464","observed_orcids":["https://orcid.org/0009-0000-4123-6464"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Mirte van der Heijden","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0009-0000-4123-6464","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115434040","display_name":"Nea Ojala","orcid":"https://orcid.org/0009-0009-9336-7920","observed_orcids":["https://orcid.org/0009-0009-9336-7920"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Nea Ojala","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0009-0009-9336-7920","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089489511","display_name":"Susanna A.M. Gr\u00f6nberg-V\u00e4h\u00e4-Koskela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Susanna Gr\u00f6nberg-V\u00e4h\u00e4-Koskela","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116155315","display_name":"Sini Raatikainen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Sini Raatikainen","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038887077","display_name":"Michael Jon Chisamore","orcid":"https://orcid.org/0009-0006-8629-8232","observed_orcids":["https://orcid.org/0009-0006-8629-8232"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J Chisamore","raw_affiliation_strings":["Merck & Co Inc, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108897040","display_name":"Katriina Johanna Jalkanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Katriina Jalkanen","raw_affiliation_strings":["Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065474301","display_name":"Tuomo Alanko","orcid":"https://orcid.org/0000-0002-1649-9040","observed_orcids":["https://orcid.org/0000-0002-1649-9040"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tuomo Alanko","raw_affiliation_strings":["Docrates Cancer Center, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0000-0002-1649-9040","affiliations":[{"raw_affiliation_string":"Docrates Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026147553","display_name":"Jukka Kemppainen","orcid":"https://orcid.org/0000-0001-9390-1198","observed_orcids":["https://orcid.org/0000-0001-9390-1198"]},"institutions":[{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]},{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jukka Kemppainen","raw_affiliation_strings":["Department of Clinical Physiology and Nuclear Medicine, Turku University Central Hospital, Turku, Finland","Docrates Cancer Center, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Physiology and Nuclear Medicine, Turku University Central Hospital, Turku, Finland","institution_ids":["https://openalex.org/I2801970007"]},{"raw_affiliation_string":"Docrates Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060932335","display_name":"Maria Hellesuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Maria Hellesuo","raw_affiliation_strings":["Docrates Cancer Center, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077967611","display_name":"Anniina F\u00e4rkkil\u00e4","orcid":"https://orcid.org/0000-0002-3558-6617","observed_orcids":["https://orcid.org/0000-0002-3558-6617"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Anniina F\u00e4rkkil\u00e4","raw_affiliation_strings":["Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland","Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]},{"raw_affiliation_string":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000164383","display_name":"Matthew Stephen Block","orcid":"https://orcid.org/0000-0001-5692-4219","observed_orcids":["https://orcid.org/0000-0001-5692-4219"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Stephen Block","raw_affiliation_strings":["Oncology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0001-5692-4219","affiliations":[{"raw_affiliation_string":"Oncology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036808328","display_name":"Tine Juul Monberg","orcid":"https://orcid.org/0000-0002-7217-2974","observed_orcids":["https://orcid.org/0000-0002-7217-2974"]},"institutions":[{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Tine Juul Monberg","raw_affiliation_strings":["Department of Oncology, National Center for Cancer Immune Therapy (CCIT DK), Copenhagen University Hospital, Herlev, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-7217-2974","affiliations":[{"raw_affiliation_string":"Department of Oncology, National Center for Cancer Immune Therapy (CCIT DK), Copenhagen University Hospital, Herlev, Denmark","institution_ids":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051043977","display_name":"Inge Marie Svane","orcid":"https://orcid.org/0000-0002-9451-6037","observed_orcids":["https://orcid.org/0000-0002-9451-6037","https://orcid.org/0000-0002-0930-8541"]},"institutions":[{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Inge Marie Svane","raw_affiliation_strings":["Department of Oncology, National Center for Cancer Immune Therapy (CCIT DK), Copenhagen University Hospital, Herlev, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-9451-6037","affiliations":[{"raw_affiliation_string":"Department of Oncology, National Center for Cancer Immune Therapy (CCIT DK), Copenhagen University Hospital, Herlev, Denmark","institution_ids":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102705197","display_name":"Johanna Unelma Maenpaa","orcid":"https://orcid.org/0000-0003-0486-6912","observed_orcids":["https://orcid.org/0000-0003-0486-6912"]},"institutions":[{"id":"https://openalex.org/I4210165436","display_name":"Docrates Cancer Center","ror":"https://ror.org/05gdz0e37","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210165436"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Johanna M\u00e4enp\u00e4\u00e4","raw_affiliation_strings":["Docrates Cancer Center, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Docrates Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I4210165436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062608835","display_name":"Suvi Sorsa","orcid":"https://orcid.org/0009-0002-1709-611X","observed_orcids":["https://orcid.org/0009-0002-1709-611X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suvi Sorsa","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047301856","display_name":"Claudia Kistler","orcid":"https://orcid.org/0009-0003-8445-4164","observed_orcids":["https://orcid.org/0009-0003-8445-4164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudia Kistler","raw_affiliation_strings":["TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072358689","display_name":"Jo\u00e3o Manuel Santos","orcid":"https://orcid.org/0000-0003-4639-1644","observed_orcids":["https://orcid.org/0000-0003-4639-1644"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Manuel dos Santos","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018878912","display_name":"Anna Kanerva","orcid":"https://orcid.org/0000-0003-3355-7393","observed_orcids":["https://orcid.org/0000-0003-3355-7393"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Anna Kanerva","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082990711","display_name":"Otto Hemminki","orcid":"https://orcid.org/0000-0002-3396-2391","observed_orcids":["https://orcid.org/0000-0002-3396-2391"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Otto Hemminki","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","Department of Urology, Helsinki University Hospital (HUS), Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Department of Urology, Helsinki University Hospital (HUS), Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080358452","display_name":"V\u00edctor Cervera-Carrasc\u00f3n","orcid":"https://orcid.org/0000-0001-6684-3666","observed_orcids":["https://orcid.org/0000-0001-6684-3666"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Victor Cervera-Carrascon","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062078543","display_name":"Akseli Hemminki","orcid":"https://orcid.org/0000-0001-7103-8530","observed_orcids":["https://orcid.org/0000-0001-7103-8530"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Akseli Hemminki","raw_affiliation_strings":["Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland","TILT Biotherapeutics Ltd, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0000-0001-7103-8530","affiliations":[{"raw_affiliation_string":"Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki Faculty of Medicine, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]},{"raw_affiliation_string":"TILT Biotherapeutics Ltd, Helsinki, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5062078543"],"corresponding_institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.78633897,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"11","first_page":"e016430","last_page":"e016430"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9190000295639038},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8989999890327454},{"id":"https://openalex.org/keywords/humoral-immunity","display_name":"humoral immunity","score":0.9779999852180481},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.6079999804496765},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-beta","display_name":"lymphotoxin","score":0.8690000176429749},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.902999997138977},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6029999852180481},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.578000009059906},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.996999979019165},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6449999809265137},{"id":"https://openalex.org/keywords/serum-proteomics","display_name":"serum proteomics","score":0.6460000276565552},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8497999906539917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6729999780654907},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6047999858856201},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5968000292778015},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5956000089645386},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5871000289916992},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5073999762535095},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4747999906539917},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.47440001368522644},{"id":"https://openalex.org/C2776548049","wikidata":"https://www.wikidata.org/wiki/Q1142875","display_name":"Humoral immunity","level":3,"score":0.375},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.35899999737739563},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3382999897003174},{"id":"https://openalex.org/C22889606","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Antibody titer","level":4,"score":0.3312999904155731},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.322299987077713},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.31349998712539673},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.30410000681877136},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.3034999966621399},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.28859999775886536},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.2847999930381775},{"id":"https://openalex.org/C2776954459","wikidata":"https://www.wikidata.org/wiki/Q193447","display_name":"Adenoviridae","level":4,"score":0.2824999988079071},{"id":"https://openalex.org/C2781261824","wikidata":"https://www.wikidata.org/wiki/Q903634","display_name":"Exosome","level":5,"score":0.2782000005245209},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.26409998536109924},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.26339998841285706},{"id":"https://openalex.org/C3017875465","wikidata":"https://www.wikidata.org/wiki/Q189146","display_name":"Cellular immunity","level":3,"score":0.2596000134944916}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1136/jitc-2026-016430","doi":"https://doi.org/10.1136/jitc-2026-016430","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-016430","pdf_url":"https://jitc.bmj.com/content/14/11/e016430.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13735263","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735263/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735263/pdf/jitc-14-11.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:42982510","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42982510","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5054ea14ffe241ceb853dabe661e3482","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5054ea14ffe241ceb853dabe661e3482","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss 11 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-016430","doi":"https://doi.org/10.1136/jitc-2026-016430","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-016430","pdf_url":"https://jitc.bmj.com/content/14/11/e016430.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2109136156","display_name":null,"funder_award_id":"811693","funder_id":"https://openalex.org/F4320310086","funder_display_name":"Helsingin Yliopisto"}],"funders":[{"id":"https://openalex.org/F4320310086","display_name":"Helsingin Yliopisto","ror":"https://ror.org/040af2s02"},{"id":"https://openalex.org/F4320321108","display_name":"Academy of Finland","ror":"https://ror.org/05k73zm37"},{"id":"https://openalex.org/F4320322282","display_name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","ror":"https://ror.org/03vxy9y38"},{"id":"https://openalex.org/F4320326591","display_name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","ror":"https://ror.org/0113k5861"},{"id":"https://openalex.org/F4320328139","display_name":"Biocenter Finland","ror":"https://ror.org/03aay6c48"},{"id":"https://openalex.org/F4320333873","display_name":"Helsinki Institute of Life Science, Helsingin Yliopisto","ror":"https://ror.org/018bh0m68"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225264755.pdf","grobid_xml":"https://content.openalex.org/works/W7225264755.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W2043987259","https://openalex.org/W2109274792","https://openalex.org/W2177059217","https://openalex.org/W2299651777","https://openalex.org/W2339729906","https://openalex.org/W2521071485","https://openalex.org/W2564495924","https://openalex.org/W2890875511","https://openalex.org/W2964272319","https://openalex.org/W3039945792","https://openalex.org/W3048380411","https://openalex.org/W3048558989","https://openalex.org/W3122662118","https://openalex.org/W3129165862","https://openalex.org/W3129646946","https://openalex.org/W3185252317","https://openalex.org/W3200405045","https://openalex.org/W4280488282","https://openalex.org/W4284675284","https://openalex.org/W4304175291","https://openalex.org/W4307171521","https://openalex.org/W4318561897","https://openalex.org/W4364381941","https://openalex.org/W4385342401","https://openalex.org/W4386030485","https://openalex.org/W4387744072","https://openalex.org/W4392455980","https://openalex.org/W4393259648","https://openalex.org/W4393935425","https://openalex.org/W4404591686","https://openalex.org/W4406675645","https://openalex.org/W4406863602","https://openalex.org/W4407157009","https://openalex.org/W4408573922","https://openalex.org/W4409764905","https://openalex.org/W4410858595","https://openalex.org/W4411100824","https://openalex.org/W4412496704","https://openalex.org/W4412902050","https://openalex.org/W4414382359","https://openalex.org/W7125259998"],"related_works":["https://openalex.org/W7117320322","https://openalex.org/W6921218875","https://openalex.org/W4406863602","https://openalex.org/W4404119989","https://openalex.org/W4410816112","https://openalex.org/W3122662118","https://openalex.org/W7125259998","https://openalex.org/W7152470639","https://openalex.org/W4388083083","https://openalex.org/W2565658110"],"abstract_inverted_index":{"Background":[0],"Oncolytic":[1],"adenoviruses":[2],"are":[3,24],"immunotherapeutic":[4],"agents":[5],"that":[6,271],"selectively":[7],"replicate":[8],"in":[9,40,63,87,328],"malignant":[10],"cells,":[11],"inducing":[12],"direct":[13],"oncolysis,":[14],"and":[15,50,55,60,78,116,128,142,158,200,207,224,230,238,242,302,317,324],"reshaping":[16],"the":[17,47,260],"tumor":[18,75,143,231],"microenvironment.":[19],"While":[20],"neutralizing":[21,185],"antibodies":[22],"(nAbs)":[23],"known":[25],"to":[26,112,147],"limit":[27],"viral":[28,311],"vector":[29],"efficacy,":[30],"emerging":[31],"evidence":[32],"suggests":[33],"they":[34],"may":[35,283],"also":[36],"have":[37],"a":[38,104,246,303],"role":[39],"improving":[41],"clinical":[42,92,166,265,297],"outcomes.":[43],"This":[44],"study":[45],"investigates":[46],"kinetics,":[48],"composition,":[49],"functional":[51,106,308],"roles":[52,309],"of":[53,177,249,264],"nAbs,":[54],"association":[56],"with":[57,66,211,221,295],"overall":[58],"survival":[59,193,223],"response":[61,202],"rate":[62],"patients":[64,85],"treated":[65],"TILT-123":[67,89],"(igrelimogene":[68],"litadenorepvec),":[69],"an":[70],"Ad5/3":[71],"oncolytic":[72,329],"adenovirus":[73],"encoding":[74],"necrosis":[76],"factor":[77],"interleukin-2.Methods":[79],"Multiple":[80],"serum":[81],"samples":[82],"from":[83],"58":[84],"enrolled":[86],"three":[88],"phase":[90],"I":[91],"trials":[93],"(":[94],"NCT04695327,":[95],"NCT04217473,":[96],"NCT05271318)":[97],"were":[98,145,293],"analyzed":[99],"for":[100,165],"anti-TILT-123":[101,205,290],"nAbs":[102,316],"using":[103,170],"cell-based":[105],"neutralization":[107],"assay.":[108],"ELISA":[109],"was":[110,153,168,219],"used":[111,146],"quantify":[113],"IgM,":[114],"IgA,":[115],"IgG":[117,206],"targeting":[118],"TILT-123.":[119,181],"Functional":[120],"antibody":[121],"signaling":[122],"studies":[123],"included":[124],"antibody-dependent":[125,129],"cellular":[126,130],"cytotoxicity":[127],"phagocytosis":[131],"(ADCP)":[132],"assays.":[133],"Serum":[134],"proteomics,":[135],"peripheral":[136],"blood":[137],"mononuclear":[138],"cell":[139],"(PBMC)":[140],"profiling,":[141],"immunofluorescence/RNA-seq":[144],"immunologically":[148],"contextualize":[149],"nAb":[150,178,251,256,278,291],"induction.":[151,252],"Survival":[152],"evaluated":[154,169],"by":[155,160],"Kaplan-Meier":[156],"analysis,":[157],"responses":[159],"RECIST":[161],"v1.1.":[162],"Biomarker":[163],"assessment":[164],"benefit":[167],"confusion":[171],"matrices.Results":[172],"Cross-trial":[173],"analysis":[174],"demonstrated":[175],"induction":[176],"titers":[179,186,257,279,292],"against":[180],"Patients":[182],"achieving":[183],"high":[184,255],"early":[187,250,288],"on-treatment":[188,254,289],"(days":[189],"8\u201322)":[190],"had":[191],"longer":[192],"(median":[194],"OS":[195],"280":[196],"vs":[197],"190":[198],"days)":[199],"higher":[201],"rates.":[203],"Baseline":[204],"IgM":[208],"levels":[209],"correlated":[210],"prolonged":[212],"OS.":[213],"ADCP":[214,300],"activity":[215,301],"on":[216],"day":[217],"36":[218],"associated":[220,294],"improved":[222,296],"disease":[225],"control.":[226],"Integrated":[227],"serum,":[228],"PBMC,":[229],"IF/RNA-seq":[232],"analyses":[233,269],"supported":[234,307],"humoral":[235,319],"immune":[236,240],"remodeling":[237],"increased":[239],"trafficking":[241],"identified":[243],"lymphotoxin-\u03b1":[244,281],"as":[245,259,276,321],"systemic":[247,305],"driver":[248],"Early":[253],"emerged":[258],"strongest":[261],"single":[262],"biomarker":[263,285],"benefit,":[266],"while":[267,299],"combinatorial":[268],"suggested":[270],"incorporating":[272],"additional":[273],"factors,":[274],"such":[275],"baseline":[277],"or":[280],"levels,":[282],"enhance":[284],"suitability.Conclusions":[286],"High":[287],"outcomes,":[298],"pro-humoral":[304],"milieu":[306],"beyond":[310],"neutralization.":[312],"These":[313],"findings":[314],"identify":[315],"antiviral":[318],"immunity":[320],"candidate":[322],"biomarkers":[323],"potential":[325],"effector":[326],"mechanisms":[327],"virus":[330],"therapy":[331],"development.":[332]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-05T00:00:00"}